Literature DB >> 7996978

Interferon beta-1b.

D E Goodkin.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7996978     DOI： 10.1016/s0140-6736(94)90484-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  More immunotherapy for multiple sclerosis.

Authors:  R A Hughes; B Sharrack
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

2.  A purchaser perspective of managing new drugs: interferon beta as a case study.

Authors:  T Walley; S Barton
Journal:  BMJ       Date:  1995-09-23

3.  Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.

Authors:  Maxwell J Heinrich; Caroline A Purcell; Andrea J Pruijssers; Yang Zhao; Charles F Spurlock; Subramaniam Sriram; Kristen M Ogden; Terence S Dermody; Matthew B Scholz; Philip S Crooke; John Karijolich; Thomas M Aune
Journal:  J Autoimmun       Date:  2019-02-28       Impact factor: 7.094

4.  Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.

Authors:  John T Tossberg; Rachel M Heinrich; Virginia M Farley; Philip S Crooke; Thomas M Aune
Journal:  J Immunol       Date:  2020-10-12       Impact factor: 5.422
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.